Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Canadian police probe 'suspicious' deaths of billionaire couple

Published 12/16/2017, 12:50 AM
© Reuters. One of two bodies is removed from the home of billionaire founder of Canadian pharmaceutical firm Apotex in Toronto

By Chris Helgren

TORONTO (Reuters) - Canadian police said they were investigating the mysterious deaths of Barry Sherman, founder of Canadian pharmaceutical firm Apotex Inc, and his wife, Honey, one of the nation's wealthiest couples whose bodies were found in their mansion on Friday.

Police said they learned of the deaths after responding to a midday (1700 GMT) medical call at the Sherman's home in an affluent section of northeast Toronto. Two bodies covered in blankets were removed from the home and loaded into an unmarked van on Friday evening.

"The circumstances of their death appear suspicious and we are treating it that way," said Constable David Hopkinson. Homicide detectives later told reporters gathered outside the home that there were no signs of forced entry.

Their neighbors, business associates and some of Canada's most powerful politicians said they were saddened by the deaths.

"Our condolences to their family & friends, and to everyone touched by their vision & spirit," Prime Minister Justin Trudeau wrote on Twitter.

Toronto Mayor John Tory said in statement he was "shocked and heartbroken" to learn of the deaths, noting that the couple had made extensive contributions to the city.

"Toronto Police are investigating, and I hope that investigation will be able to provide answers for all of us who are mourning this tremendous loss," Tory said.

The Shermans recently listed their home for sale for nearly C$7 million ($5.4 million). A real estate agent discovered the bodies in the basement while preparing for an open house, the Toronto Globe and Mail reported, citing a relative.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sherman, 75, founded privately held Apotex in 1974, growing it by introducing large numbers of low-cost generic drugs that took market share from branded pharmaceuticals. He stepped down as chief executive in 2012 but remained executive chairman.

Forbes has estimated Sherman's fortune at $3.2 billion.

Apotex is the world's No. 7 generic drugmaker with 11,000 employees and annual sales of more than C$2 billion in more than 45 countries, according to its website.

The couple was known for their philanthropy, giving tens of millions of dollars to hospitals, universities and Jewish organizations, CBC reported.

"They were extremely successful in business, but also very, very giving people," former Ontario Premier Bob Rae told CBC. "It's going to be a very, very big loss."

The Globe and Mail reported in February that Lobbying Commissioner Karen Shepherd was investigating a complaint about a 2015 political fundraiser that Trudeau had attended.

(Writing and additional reporting by Julie Gordon in Vancouver; Editing by Jim Finkle, Leslie Adler and Paul Tait)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.